Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Zsolt Szegedi"'
Autor:
Livia Rojko, Zsolt Megyesfalvi, Eszter Czibula, Lilla Reiniger, Vanda Teglasi, Zsolt Szegedi, Zoltan Szallasi, Balazs Dome, Judit Moldvay
Publikováno v:
Thoracic Cancer, Vol 11, Iss 11, Pp 3193-3204 (2020)
Background Metastatic lung cancer is a debilitating disease, but with the advances in immunotherapy, therapeutic options have vastly increased. Numerous complete blood count parameters (CBC) have been described as easily accessible biomarkers that mi
Externí odkaz:
https://doaj.org/article/8d86fa3320a8435ab281b82d037f5719
Publikováno v:
Hematológia–Transzfuziológia. 54:198-204
Összefoglaló. A vérkészítmény-irradiáció célja a transzfúzió-asszociált graft-versus-host betegség (TA-GVHD) megelőzése a magvas sejtek nukleinsav-állományának szelektív károsításával. Az irradiáció hátránya a káliumtartal
Autor:
Eszter Czibula, Zsolt Szegedi, Lilla Reiniger, Judit Moldvay, Zsolt Megyesfalvi, Lívia Rojkó, Vanda Téglási, Zoltan Szallasi, Balazs Dome
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 11, Iss 11, Pp 3193-3204 (2020)
Thoracic Cancer, Vol 11, Iss 11, Pp 3193-3204 (2020)
Background Metastatic lung cancer is a debilitating disease, but with the advances in immunotherapy, therapeutic options have vastly increased. Numerous complete blood count parameters (CBC) have been described as easily accessible biomarkers that mi
Autor:
Zsolt Szegedi, Sándor András Boldogh, Tamás Visnyovszky, Béla Habarics, Szabolcs Lengyel, Cecília Krajnyák, Róbert Horváth
Publikováno v:
Ornis Hungarica, Vol 24, Iss 2, Pp 18-31 (2016)
The Corncrake is a threatened umbrella species for wet meadows, which mostly depends on managed grasslands. Therefore, effective conservation requires bird-friendly land management schemes and subsidies. Although the most important populations in Hun
Autor:
Rita Puskás, Zsolt Szegedi, László Prés, Judit Moldvay, Lívia Rojkó, Dorottya Fejes, Katalin Fábián, Zoltan Szallasi, Balazs Dome, Orsolya Pipek, Tímea Kakuk
Publikováno v:
Fabian, K, Puskás, R, Kakuk, T, Prés, L, Fejes, D, Szegedi, Z, Rojkó, L, Szallasi, Z I, Döme, B, Pipek, O & Moldvay, J 2017, ' Renal Impairment Hampers Bisphosphonate Treatment in a Quarter of Lung Cancer Patients with Bone Metastasis ', Basic and Clinical Pharmacology and Toxicology, vol. 122, no. 1, pp. 126-132 . https://doi.org/10.1111/bcpt.12876
Renal function impairment in lung cancer patients with bone metastases was investigated, as this can limit the application of bisphosphonates representing the gold standard in the management of such cases. Clinicopathological data of 570 lung cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::103c1b1b459ea15dad93993db5b27564
https://orbit.dtu.dk/en/publications/82a9eb2f-a710-4a11-bb84-274633a4ac11
https://orbit.dtu.dk/en/publications/82a9eb2f-a710-4a11-bb84-274633a4ac11
Autor:
György Mészáros, István Kövesdi, M. Idei, Frigyes Wáczek, Ferenc Hollósy, György Kéri, Anikó Horváth, Laszlo Orfi, Marianna Mák, Zsolt Szegedi, Béla Szende
Publikováno v:
Letters in Peptide Science. 6:325-333
A parallel combinatorial library of over 1600 compounds has been designed and synthesized for the development of new potential peptidomimetic protein tyrosine kinase (PTK) inhibitor leads. These peptidomimetic molecules are aimed at intervening with
Coexpression of p53 and tissue transglutaminase genes in human normal and pathologic adrenal tissues
Autor:
Edit Gláz, Attila Bezzegh, Károly Rácz, Miklós Tóth, Béla Szende, Ibolya Varga, Judit Moldvay, Zsolt Szegedi, Vilmos Adleff
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 66:27-33
The presence of p53 and tissue transglutaminase (tTG) gene expressions was investigated in human normal and pathologic adrenal tissues with two aims (1) to determine the tissue content of p53 protein, its messenger ribonucleic acid (mRNA) and, especi
Autor:
György Kéri, Béla Szende, Zsolt Szegedi, Ferenc Hollósy, István Peták, Tibor Vántus, Judit Erchegyi, Anikó Horváth, Aviv Gazit, Istvan Teplan, M. Idei, Laszlo Orfi
Publikováno v:
Peptide Science — Present and Future ISBN: 0792352718
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d4e39d9bd2e953d019f56f91715db4e
https://doi.org/10.1007/0-306-46864-6_12
https://doi.org/10.1007/0-306-46864-6_12
Autor:
M. Idei, György Kéri, Gergely Szántó, Ferenc Hollósy, Istvan Teplan, Zsolt Szegedi, Laszlo Orfi, Judit Erchegyi, Béla Szende, Aviv Gazit, Anikó Horváth
Publikováno v:
American Peptide Symposia ISBN: 0792351606
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::760ad13aaad39b6a459be611cffa6ed1
https://doi.org/10.1007/0-306-46862-x_75
https://doi.org/10.1007/0-306-46862-x_75
Autor:
Doris Hafenbradl, Laszlo Orfi, György Kéri, Péter Bánhegyi, István Varga, Gerhard Müller, Zoltán Varga, János Pató, Axel Ullrich, Ildikó Szilágyi, Zsolt Székelyhidi, Zoltán Horváth, Dániel Eros, Jenö Marosfalvi, Zoltán Greff, Bálint Hegymegi-Barakonyi, Frigyes Wáczek, Csaba Szántai-Kis, Bert Klebl, István Szabadkai, Zsolt Szegedi
Publikováno v:
Assay and drug development technologies. 3(5)
Kinase inhibitors are at the forefront of modern drug research, where mostly three technologies are used for hit-and-lead finding: high throughput screening of random libraries, three-dimensional structure-based drug design based on X-ray data, and f